Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women

John Repke, Timothy R. Townsend, Jacqueline S. Coberly, Geraldine M. McQuillan, Neal A. Halsey, Thomas C. Quinn

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Five (0.74%) of 678 women delivering in 1985 at a tertiary referral hospital for high-risk pregnancies and 16 (1.34%) of 1198 women visiting an urban prenatal obstetrics clinic in 1986-1987 had serologic evidence of human immunodeficiency virus type 1 (HIV-1) infection. Unlinked testing (removal of personal identifiers from the blood specimen and the epidemiologic data sheet) of residual serum from hepatitis B virus serologic testing was used. Neither age, marital status, payor status, nor serologic markers of hepatitis B virus infection was useful in identifying women at riskfor HIV-1 infection. As a result of these data, we have initiated a program in which counseling is offered to all women and testing for those who consent. Unlinked testing of women who refuse consent is performed for epidemiologic purposes. This will allow us to continue to plan for health care resource needs and to track the course of the epidemic in various subgroups of pregnant women.

Original languageEnglish (US)
Pages (from-to)293-295
Number of pages3
JournalAmerican Journal of Perinatology
Volume9
Issue number4
DOIs
StatePublished - Jan 1 1992

Fingerprint

Seroepidemiologic Studies
HIV-1
Pregnant Women
Virus Diseases
Hepatitis B virus
High-Risk Pregnancy
Health Resources
Marital Status
Tertiary Care Centers
Obstetrics
Counseling
Delivery of Health Care
Serum

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Repke, J., Townsend, T. R., Coberly, J. S., McQuillan, G. M., Halsey, N. A., & Quinn, T. C. (1992). Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women. American Journal of Perinatology, 9(4), 293-295. https://doi.org/10.1055/s-2007-999243
Repke, John ; Townsend, Timothy R. ; Coberly, Jacqueline S. ; McQuillan, Geraldine M. ; Halsey, Neal A. ; Quinn, Thomas C. / Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women. In: American Journal of Perinatology. 1992 ; Vol. 9, No. 4. pp. 293-295.
@article{ac9c6c19fc404354b2ba2f212fb2616a,
title = "Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women",
abstract = "Five (0.74{\%}) of 678 women delivering in 1985 at a tertiary referral hospital for high-risk pregnancies and 16 (1.34{\%}) of 1198 women visiting an urban prenatal obstetrics clinic in 1986-1987 had serologic evidence of human immunodeficiency virus type 1 (HIV-1) infection. Unlinked testing (removal of personal identifiers from the blood specimen and the epidemiologic data sheet) of residual serum from hepatitis B virus serologic testing was used. Neither age, marital status, payor status, nor serologic markers of hepatitis B virus infection was useful in identifying women at riskfor HIV-1 infection. As a result of these data, we have initiated a program in which counseling is offered to all women and testing for those who consent. Unlinked testing of women who refuse consent is performed for epidemiologic purposes. This will allow us to continue to plan for health care resource needs and to track the course of the epidemic in various subgroups of pregnant women.",
author = "John Repke and Townsend, {Timothy R.} and Coberly, {Jacqueline S.} and McQuillan, {Geraldine M.} and Halsey, {Neal A.} and Quinn, {Thomas C.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1055/s-2007-999243",
language = "English (US)",
volume = "9",
pages = "293--295",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "4",

}

Repke, J, Townsend, TR, Coberly, JS, McQuillan, GM, Halsey, NA & Quinn, TC 1992, 'Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women', American Journal of Perinatology, vol. 9, no. 4, pp. 293-295. https://doi.org/10.1055/s-2007-999243

Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women. / Repke, John; Townsend, Timothy R.; Coberly, Jacqueline S.; McQuillan, Geraldine M.; Halsey, Neal A.; Quinn, Thomas C.

In: American Journal of Perinatology, Vol. 9, No. 4, 01.01.1992, p. 293-295.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Seroprevalence of Human Immunodeficiency Virus Type 1 Among Pregnant Women

AU - Repke, John

AU - Townsend, Timothy R.

AU - Coberly, Jacqueline S.

AU - McQuillan, Geraldine M.

AU - Halsey, Neal A.

AU - Quinn, Thomas C.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Five (0.74%) of 678 women delivering in 1985 at a tertiary referral hospital for high-risk pregnancies and 16 (1.34%) of 1198 women visiting an urban prenatal obstetrics clinic in 1986-1987 had serologic evidence of human immunodeficiency virus type 1 (HIV-1) infection. Unlinked testing (removal of personal identifiers from the blood specimen and the epidemiologic data sheet) of residual serum from hepatitis B virus serologic testing was used. Neither age, marital status, payor status, nor serologic markers of hepatitis B virus infection was useful in identifying women at riskfor HIV-1 infection. As a result of these data, we have initiated a program in which counseling is offered to all women and testing for those who consent. Unlinked testing of women who refuse consent is performed for epidemiologic purposes. This will allow us to continue to plan for health care resource needs and to track the course of the epidemic in various subgroups of pregnant women.

AB - Five (0.74%) of 678 women delivering in 1985 at a tertiary referral hospital for high-risk pregnancies and 16 (1.34%) of 1198 women visiting an urban prenatal obstetrics clinic in 1986-1987 had serologic evidence of human immunodeficiency virus type 1 (HIV-1) infection. Unlinked testing (removal of personal identifiers from the blood specimen and the epidemiologic data sheet) of residual serum from hepatitis B virus serologic testing was used. Neither age, marital status, payor status, nor serologic markers of hepatitis B virus infection was useful in identifying women at riskfor HIV-1 infection. As a result of these data, we have initiated a program in which counseling is offered to all women and testing for those who consent. Unlinked testing of women who refuse consent is performed for epidemiologic purposes. This will allow us to continue to plan for health care resource needs and to track the course of the epidemic in various subgroups of pregnant women.

UR - http://www.scopus.com/inward/record.url?scp=0026704627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026704627&partnerID=8YFLogxK

U2 - 10.1055/s-2007-999243

DO - 10.1055/s-2007-999243

M3 - Article

VL - 9

SP - 293

EP - 295

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 4

ER -